Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8784599 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
Condition: Chronic Hepatitis B
Intervention: Drug: Lamivudine/ Placebo 100mg daily

Indicates status has not been verified in more than two years